Emma Reeve Buys Shares of WHWK
Emma Reeve purchased 38,040 shares of WHWK on June 12, 2026.
Key Points
- Emma Reeve bought 38,040 shares of WHWK on June 12, 2026, with shares trading at $4.16.
- WHWK shares were trading at $4.16, with peer funds holding significant stakes.
- Analysts from Citizens and Jones Trading initiated buy ratings with targets of $8 and $7, respectively.
Emma Reeve purchased 38,040 shares of WHWK on June 12, 2026. This insider buying activity occurred as WHWK shares traded around $4.16.
What Changed in Emma Reeve's WHWK Position
Emma Reeve's purchase of 38,040 shares on June 12, 2026, marks a significant addition to her holdings in WHWK. The transaction was not part of a pre-planned trading program.
Other Institutional Activity in WHWK
Several major funds maintain substantial stakes in WHWK. QVT Financial LP holds 4,615,709 shares valued at approximately $15.92 million. Orbimed Advisors LLC owns 4,166,000 shares worth about $14.37 million. Suvretta Capital Management, LLC has 3,700,000 shares valued at around $12.77 million. Acuta Capital Partners, LLC and Avoro Capital Advisors LLC hold 3,410,402 and 2,849,402 shares, respectively, with values of $11.77 million and $9.83 million.
WHWK Stock Snapshot
WHWK shares are trading at $4.16. The stock's trading activity has been of interest to several institutional investors, as reflected by the large holdings of major funds.
Insider Buying and Selling at Whitehawk Therapeutics, Inc.
On June 12, 2026, several insiders, including Emma Reeve, Castelein Caley, Desai Neil, Maroun Richard, Zhao Baiteng, and Aghazadeh Behzad, each purchased 38,040 shares of WHWK. These transactions were not part of any pre-arranged trading plans.
Analysts Set New Price Targets
On April 16, 2026, Citizens initiated coverage of WHWK with a 'buy' rating and an $8 price target. Earlier, on December 22, 2025, Jones Trading also initiated coverage with a 'buy' rating and a $7 price target. The consensus among analysts is positive, with a mean target price reflecting optimism about WHWK's future performance.
About WHWK
WHWK operates in a sector that involves [brief description of industry, if available]. The company is known for [brief description of what the company does]. Further details about its operations, leadership, and headquarters are not specified in the current data.
Bottom Line
Emma Reeve's recent purchase of WHWK shares suggests confidence in the company's prospects. This insider activity, along with substantial institutional holdings, indicates continued interest in WHWK. Analyst coverage with positive ratings further supports this interest. However, as with all 13F filings and insider transactions, these are backward-looking and may not reflect the current situation.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.